Actively Recruiting
A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
Led by The Third Xiangya Hospital of Central South University · Updated on 2026-02-19
600
Participants Needed
1
Research Sites
552 weeks
Total Duration
On this page
Sponsors
T
The Third Xiangya Hospital of Central South University
Lead Sponsor
C
Changsha Hospital for Maternal and Child Health Care
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.
CONDITIONS
Official Title
A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of retained products of conception
- Ultrasound shows the maximum lesion diameter is 0.5 cm or larger
- Female participants aged 18 to 45 years
You will not qualify if you...
- Active bleeding requiring immediate surgical intervention
- Presence of obvious infection
- Severe organ dysfunction, including coagulation dysfunction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China, 410013
Actively Recruiting
Research Team
D
Dabao MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here